Authorization

Moderna's COVID-19 Vaccine Gets Conditional Marketing Authorization In South Korea

(RTTNews) - Moderna Inc. (MRNA) said that the Ministry of Food and Drug Safety of South Korea has approved the company's application for Conditional Marketing Authorization for its mRNA vaccine against COVID-19.

GC Pharma in South Korea is the company's marketing authorization holder and distributor of Moderna's COVID-19 vaccine for the South Korea.

Moderna's COVID-19 vaccine is authorized pursuant to a Conditional Marketing Authorization in South Korea for use in adults aged 18 years and older.

Moderna announced earlier this year that it plans to open a commercial subsidiary in South Korea in 2021.

South Korea has secured access to 40 million doses of COVID-19 Vaccine Moderna.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Август 2022    »
ПнВтСрЧтПтСбВс
1234567
891011121314
15161718192021
22232425262728
293031